FindTrial
Sign In

peripheral blood lymphocyte therapy

BIOLOGICAL6 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI), Dana-Farber Cancer Institute, The Cleveland Clinic

Conditions

Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic TumorKidney CancerLeukemiaLymphomaMultiple Myeloma and Malignant Plasma Cell NeoplasmsMultiple Myeloma and Plasma Cell Neoplasm

Phase 1

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
CompletedNCT00376480
Dana-Farber Cancer InstituteLeukemia, Myelodysplastic Syndromes
Start: 2005-06-30End: 2018-05-16Updated: 2019-07-05
Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant
TerminatedNCT00469820
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLeukemia, Multiple Myeloma and Plasma Cell Neoplasm
Start: 2007-04-30End: 2010-03-31Updated: 2014-03-21

Phase 2

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
TerminatedNCT00066417
National Heart, Lung, and Blood Institute (NHLBI)Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases
End: 2007-01-31Target: 51Updated: 2013-05-01
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
CompletedNCT00003572
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLeukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm +1
Start: 1998-08-31End: 2002-04-30Target: 20Updated: 2014-05-02
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
CompletedNCT00003887
Fred Hutchinson Cancer CenterBreast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor +9
Start: 1998-08-31End: 2003-02-28Updated: 2011-11-30
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
TerminatedNCT00589602
The Cleveland ClinicChronic Myeloproliferative Disorders, Leukemia, Lymphoma +4
Start: 2004-01-31End: 2014-12-31Updated: 2017-05-30